Change of Renal Function and Bone Mineral Density in CHB Patients Switch From TDF to TAF vs. Maintaining TDF

NCT03356834 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

575

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: Tenofovir alafenamide(TAF)
DRUG: Tenofovir disoproxil fumarate(TDF)

Sponsor

Humanity and Health Research Centre